Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Jun 16, 2023; 11(17): 4105-4116
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4105
Figure 1
Figure 1 Morphological and pathological evaluation of the bone marrow at the time of initial diagnosis of myelodysplastic syndrome and in the flared inflammatory episode. A and B: Morphological (A) and pathological (B) evaluation of the bone marrow at the time of initial diagnosis of myelodysplastic syndrome showed significantly increased cellularity with an increased percentage of myeloblasts that accounted for 13% of the total nucleated cells; C and D: Morphological (C) and pathological (D) reevaluation of the bone marrow in the flared inflammatory episode with agranulocytosis and severe anemia showed heavily decreased cellularity with regression of the leukemic cells.